CLONICAINE Trademark

Trademark Overview

On Monday, August 17, 2020, a trademark application was filed for CLONICAINE with the United States Patent and Trademark Office. The USPTO has given the CLONICAINE trademark a serial number of 90118492. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 29, 2024. This trademark is owned by CAD Therapeutics, Inc.. The CLONICAINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of Hot Flashes; Pharmaceutical preparations for the treatment of Post Traumatic Stress Disorder

Providing a website featuring information about investigational medical devices, diagnostics and drugs
clonicaine

General Information

Serial Number90118492
Word MarkCLONICAINE
Filing DateMonday, August 17, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of Hot Flashes; Pharmaceutical preparations for the treatment of Post Traumatic Stress Disorder
Goods and ServicesProviding a website featuring information about investigational medical devices, diagnostics and drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 19, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCAD Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10013
Party NameCAD Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10013

Trademark Events

Event DateEvent Description
Thursday, August 20, 2020NEW APPLICATION ENTERED
Saturday, September 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 11, 2020ASSIGNED TO EXAMINER
Monday, December 14, 2020NON-FINAL ACTION WRITTEN
Monday, December 14, 2020NON-FINAL ACTION E-MAILED
Monday, December 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 20, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 20, 2021SOU EXTENSION 1 FILED
Monday, December 20, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 20, 2022SOU TEAS EXTENSION RECEIVED
Monday, June 20, 2022SOU EXTENSION 2 FILED
Monday, June 20, 2022SOU EXTENSION 2 GRANTED
Wednesday, June 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 20, 2022SOU EXTENSION 3 FILED
Tuesday, December 20, 2022SOU EXTENSION 3 GRANTED
Thursday, December 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 7, 2023SOU EXTENSION 4 FILED
Wednesday, June 7, 2023SOU EXTENSION 4 GRANTED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 3, 2023SOU EXTENSION 5 FILED
Wednesday, November 8, 2023SOU EXTENSION 5 GRANTED
Monday, July 29, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 29, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

clonicaine pharmaceutical treatment preparations about information investigational devices drugs diagnostics featuring